haloperidol has been researched along with methyldopa in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (55.26) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (21.05) | 29.6817 |
2010's | 9 (23.68) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Davydova, ON; Krendal', FP; Kudrin, AN | 1 |
Bhattacharya, SK; Das, PK; Mukhopadhyay, SN; Reddy, PK | 1 |
Nadel, I; Wallach, M | 1 |
Korobov, NV; Uspenskiĭ, AE | 1 |
Thornton, WE | 1 |
Clyne, KE; Juhl, R | 1 |
Fujimoto, H; Kawai, H; Masuda, T; Saito, S | 1 |
Chouinard, G; Serrano, PM; Tetreault, L | 1 |
Dunkley, B; Friedman, E; Gershion, S; Sanghvi, I | 1 |
Bergmann, F; Chaimovitz, M; Pasternak, V; Ramu, A | 1 |
Aihara, H; Kasai, A; Sakai, T | 1 |
Boudier, HA; Cools, AR; Geilen, W; Van Rossum, JM | 1 |
Bartholini, G; Pletscher, A | 1 |
Anagnoste, B; Battista, AF; Fuxe, K; Goldstein, M; Ohmoto, T | 1 |
Atkinson, M; Hartley, D; Lunts, LH; Ritchie, AC | 1 |
Gazengel, J; Lhermitte, F; Marteau, R; Peterfalvi, M; Serdaru, M | 1 |
Dhawan, BN; Srimal, RC | 1 |
Bergmann, F | 1 |
Arbogast, R; Palfreyman, MG; Wagner, J; Zreika, M | 1 |
Forman, LJ; Meites, J; Miki, N; Ramos, T; Sonntag, WE | 1 |
Fernstrom, JD; Sved, AF; Wiggins, JF | 1 |
Markova, LN; Ostroumova, TV | 1 |
Iwakawa, Y; Kohyama, J; Shimohira, M | 1 |
Bergman, H; El-Sayeh, HG; Rathbone, J; Soares-Weiser, K | 1 |
3 review(s) available for haloperidol and methyldopa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drugs affecting monoamines in the basal ganglia.
Topics: Amines; Animals; Atropine; Barbiturates; Basal Ganglia; Biogenic Amines; Carbon Isotopes; Chlorpromazine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Haloperidol; Hydroxyindoleacetic Acid; Methyldopa; Norepinephrine; Phenylacetates; Rabbits; Rats; Tranquilizing Agents; Tritium | 1972 |
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
Topics: Adrenergic Uptake Inhibitors; Anti-Dyskinesia Agents; Antipsychotic Agents; Celiprolol; Disease Progression; Dopamine Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Humans; Methyldopa; Randomized Controlled Trials as Topic; Reserpine; Tetrabenazine; Tiapamil Hydrochloride | 2018 |
35 other study(ies) available for haloperidol and methyldopa
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines].
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cardiac Glycosides; Cats; Drug Interactions; Haloperidol; Humans; Hypertension; Lithium; Methyldopa; Methylphenidate; Monoamine Oxidase Inhibitors; Parasympatholytics; Phenothiazines; Propranolol; Tranquilizing Agents | 1977 |
Role of brain monoamines in the anticonvulsant effect of imipramine in albino rats.
Topics: Animals; Anticonvulsants; Apomorphine; Catecholamines; Ditiocarb; Dopamine; Drug Interactions; Electroshock; Female; Fenclonine; Haloperidol; Hydroxydopamines; Imipramine; Male; Methyldopa; Methyltyrosines; Methysergide; Norepinephrine; Phenoxybenzamine; Propranolol; Rats; Reserpine; Seizures; Serotonin | 1976 |
Drug interaction between haloperidol and methyldopa.
Topics: Aged; Aggression; Drug Interactions; Female; Haloperidol; Humans; Mental Disorders; Methyldopa | 1979 |
[Facilitation of the effects of L-DOPA by alpha-methyldopa].
Topics: Animals; Blood Pressure; Catalepsy; Cats; Dopamine; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Levodopa; Male; Methyldopa; Mice; Nictitating Membrane; Reserpine | 1976 |
Dementia induced by methyldopa with haloperidol.
Topics: Adult; Anxiety; Dementia; Drug Synergism; Haloperidol; Humans; Hypertension; Male; Methyldopa; Middle Aged | 1976 |
Tardive dyskinesia.
Topics: Choline; Deanol; Dopamine Antagonists; Haloperidol; Humans; Methyldopa; Movement Disorders; Papaverine; Parasympathomimetics; Reserpine; Tetrabenazine | 1976 |
[Distribution of neurotensin-like immunoreactivity (NTLI) and neurotensin receptor in the rat brain and effects of various drugs on NTLI concentration and NT receptor in the rat cerebral cortex].
Topics: Animals; Brain; Cerebral Cortex; Dopamine; Haloperidol; In Vitro Techniques; Injections, Intraventricular; Levodopa; Male; Methyldopa; Neuropeptides; Rats; Receptors, Neurotensin; Receptors, Neurotransmitter | 1988 |
Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Blood Pressure; Body Weight; Drug Synergism; Female; Haloperidol; Humans; Male; Methyldopa; Psychiatric Status Rating Scales; Pulse; Reticulocytes; Schizophrenia; Time Factors; Vertigo | 1973 |
Comparison of behavioral and cardiovascular effects of L-DOPA and 5-HTP in conscious dogs.
Topics: Animals; Behavior, Animal; Blood Pressure; Cardiovascular System; Dihydroxyphenylalanine; Dogs; Female; Fenclonine; Haloperidol; Hydrazines; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Intravenous; Male; Methyldopa; Methysergide; Serotonin | 1972 |
Compulsive gnawing in rats after implantation of drugs into the ventral thalamus. A contribution to the mechanism of morphine action.
Topics: Amphetamine; Animals; Apomorphine; Brain; Chlorpromazine; Compulsive Behavior; Corpus Striatum; Disulfiram; Dose-Response Relationship, Drug; Drug Synergism; Fenclonine; Haloperidol; Humans; Meperidine; Methadone; Methyldopa; Methyltyrosines; Morphine; Nalorphine; Phenoxybenzamine; Phentolamine; Pimozide; Rats; Thalamus | 1974 |
The effect of dopamine on peripheral vasculature of the rat.
Topics: Animals; Blood Pressure; Blood Vessels; Cocaine; Constriction; Depression, Chemical; Disulfiram; Dopamine; Dopamine Antagonists; Drug Synergism; Ephedrine; Ergotamine; Haloperidol; Hindlimb; Kidney; Male; Methyldopa; Morphine; Norepinephrine; Perfusion; Propranolol; Rats; Reserpine; Stimulation, Chemical; Tyramine | 1972 |
Pharmacological analysis of dopamine-induced inhibition and excitation of neurones of the snail Helix aspersa.
Topics: Animals; Apomorphine; Butyrophenones; Dopamine; Dopamine Antagonists; Droperidol; Epinephrine; Ergot Alkaloids; Haloperidol; In Vitro Techniques; Isoproterenol; Methyldopa; Neurons; Norepinephrine; Phenylephrine; Snails; Time Factors | 1974 |
Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent.
Topics: 5-Hydroxytryptophan; Animals; Benzyl Compounds; Dihydroxyphenylalanine; Dioxoles; Drug Interactions; Electroencephalography; Haloperidol; Haplorhini; Humans; Hydrazines; Hyperkinesis; Injections, Intraperitoneal; Methyldopa; Methyltyrosines; Picolinic Acids; Piperazines; Pyrimidines; Tremor | 1973 |
Saligenin analogs of l-DOPA and dl-alpha-methyl-DOPA.
Topics: Animals; Antiparkinson Agents; Blood Pressure; Desoxycorticosterone; Dihydroxyphenylalanine; Dopa Decarboxylase; Guinea Pigs; Haloperidol; Kidney; Methanol; Methyldopa; Methyltyrosines; Mice; Myocardium; Norepinephrine; Rats; Tyrosine | 1974 |
[Pharmacological analysis of a case of postanoxic intention and action myoclonus].
Topics: 5-Hydroxytryptophan; Alcohols; Anticonvulsants; Benzoates; Carbamazepine; Chlorpromazine; Diazepam; Dibenzazepines; Dopamine; Ergotamine; Female; Haloperidol; Humans; Hypoxia, Brain; Methotrimeprazine; Methyldopa; Methysergide; Middle Aged; Myoclonus; Norepinephrine; Phenobarbital; Pyrrolidines; Stereotaxic Techniques; Sulfonamides; Tranquilizing Agents; Trihexyphenidyl | 1971 |
An analysis of methylphenidate induced gnawing in guinea pigs.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Drug Antagonism; Female; Guinea Pigs; Haloperidol; Male; Methyldopa; Methylphenidate; Methyltyrosines; Tranylcypromine | 1970 |
Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
Topics: Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Fenclonine; Haloperidol; Humans; Male; Methyldopa; Methyltyrosines; Rats; Stereotyped Behavior; Stimulation, Chemical | 1982 |
A method for measuring monoamine turnover in animals using an irreversible inhibitor of aromatic L-amino acid decarboxylase, DL-alpha-mono fluoromethyldopa.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Biogenic Amines; Brain Chemistry; Dopamine; Haloperidol; Hydroxyindoleacetic Acid; Male; Methyldopa; Mice; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Species Specificity; Tetrahydronaphthalenes; Time Factors | 1984 |
Comparison of the effects of central acting drugs on prolactin release in young and old male rats.
Topics: Age Factors; Animals; Haloperidol; Male; Methyldopa; Morphine; Naloxone; Prolactin; Quinolines; Quipazine; Radioimmunoassay; Rats | 1981 |
Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies.
Topics: Animals; Deoxyepinephrine; Dopamine; Haloperidol; In Vitro Techniques; Male; Methyldopa; Nordefrin; Pituitary Gland; Prolactin; Rats; Receptors, Dopamine; Thyrotropin-Releasing Hormone; Time Factors | 1980 |
[Effect of inhibitors of synthesis of dopamine and its antagonists on Hydra attenuata regeneration].
Topics: alpha-Methyltyrosine; Animals; Dopamine; Dopamine Antagonists; Haloperidol; Hydra; Methyldopa; Monoiodotyrosine; Regeneration; Spiperone | 2000 |
Rapid-eye-movement sleep in jittery infants.
Topics: Female; Haloperidol; Humans; Infant; Male; Maternal-Fetal Exchange; Methyldopa; Movement Disorders; Pregnancy; Reserpine; Sleep, REM | 2002 |